Biomedical Open Access Journals

The Use of Scan Pet for Lung Cancer | Lung cancer is the most common cause of cancer death in Western countries, and non-small cell lung cancer (NSCLC) accounts for 80% of these neoplasms. Despite the efforts in the early diagnosis and advances in the treatment of these patients, overall survival remains very low, approximately 18% at 5 years2. The relatively low (30-50%) survival of patients with limited, potentially curable disease probably reflects the inability to detect advanced disease at initial staging. The stage of the disease is considered the most important prognostic factor and determines the therapeutic options. It is therefore crucial to perform a correct initial staging for the administration of an appropriate treatment, avoiding unnecessary surgeries. In this sense, the identification of contralateral mediastinal lymphatic involvement and distant metastasis is particularly relevant, since it classifies patients as stages IIIB and IV, excluding them from a curative treatment. For More: Biomedical Journals Publishers : https://biomedres.us/